Improving Performance in Drivers With Mild Cognitive Impairment
NCT ID: NCT01935219
Last Updated: 2020-01-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
66 participants
INTERVENTIONAL
2013-08-31
2019-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Our hypotheses are that the study intervention will improve performance on a driving simulator and will improve (i) executive function, specifically attention and planning, (ii) useful field of view, (iii) mood, (iv) quality of life, and (v) reported motor vehicle crashes and driving infractions.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Driving Ability Among People With Mild Cognitive Impairment
NCT01608256
Making Memory Better for Seniors With Mild Cognitive Impairment
NCT01532739
Cognitive Rehabilitation for People With Multiple Sclerosis
NCT06179134
Effects of Online Training Aimed at Increasing Participation in Everyday Life During a Pandemic (SCD Online).
NCT04439500
Vision-based Speed of Processing Cognitive Training and Mild Cognitive Impairment
NCT02559063
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Goal Management Training + Processing Speed Training
Group receives both Goal Management Training and as well as Processing Speed Training using DriveSharp software.
Goal Management Training
9 weeks, 2 hour session/week, 1 hour/day homework (6 days/week), 2 x 0.5 hour sessions with trainer
Processing Speed Training
9 weeks, a total of 10 hours of computer-based processing speed training; 60-75 minutes/week
Processing Speed Training + Brain Health Workshop
Group receives both Processing Speed Training (using DriveSharp) and participates in a Brain Health Workshop that is matched to Goal Management Training for session length and contact with trainer.
Processing Speed Training
9 weeks, a total of 10 hours of computer-based processing speed training; 60-75 minutes/week
Brain Health Workshop
9 weeks, 2 hour session/week, 1 hour/day homework (6 days/week), 2 x 0.5 hour sessions with trainer
Brain Health Workshop + computer assignments
Group participates in Brain Health Workshop and is provided with computer assignments to match for time spent on the computer in the other arms.
Brain Health Workshop
9 weeks, 2 hour session/week, 1 hour/day homework (6 days/week), 2 x 0.5 hour sessions with trainer
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Goal Management Training
9 weeks, 2 hour session/week, 1 hour/day homework (6 days/week), 2 x 0.5 hour sessions with trainer
Processing Speed Training
9 weeks, a total of 10 hours of computer-based processing speed training; 60-75 minutes/week
Brain Health Workshop
9 weeks, 2 hour session/week, 1 hour/day homework (6 days/week), 2 x 0.5 hour sessions with trainer
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* currently driving or voluntarily stopped driving within the past year
* fluent in English
Exclusion Criteria
* alcohol/substance abuse
* stroke with residual motor /sensory deficit
* traumatic brain injury
* seizure in the past two years
* Parkinson's disease
* Multiple sclerosis
* untreated sleep apnea
* history of motion sickness
* history of dizziness, vertigo
* active primary psychiatric disorder requiring treatment
* on a dose of cognitive enhancing medication for less than 3 months
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Unity Health Toronto
OTHER
Sunnybrook Health Sciences Centre
OTHER
Lakehead University
OTHER
McGill University
OTHER
University Health Network, Toronto
OTHER
Michael Garron Hospital
OTHER
Centre for Addiction and Mental Health
OTHER
Baycrest
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gary Naglie
Chief of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gary Naglie, MD
Role: PRINCIPAL_INVESTIGATOR
Baycrest
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Baycrest Health Sciences
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CIHR MOP-119580
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.